List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #101 to #150.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Carmustine (BiCNU) → Carmustine (BCNU)
- Carmustine wafer, polifeprosan 20 (Gliadel) → Carmustine wafer, polifeprosan 20 (Gliadel wafer)
- Castleman’s disease → Castleman disease
- Cemiplimab (REGN2810) → Cemiplimab (Libtayo)
- Central nervous system (CNS) cancer → Anaplastic glioma
- Chemotherapy → Drug index
- Chimeric antigen receptor T cells (CAR-T) → Cellular therapy conditioning regimens
- Chronic lymphocytic leukaemia (CLL/SLL) → Chronic lymphocytic leukemia
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) → Chronic lymphocytic leukemia
- Chronic lymphocytic leukemia (CLL/SLL) → Chronic lymphocytic leukemia
- Chronic myelogenous leukaemia → Chronic myeloid leukemia
- Chronic myelogenous leukemia → Chronic myeloid leukemia
- Chronic myelogenous leukemia, pediatric → Chronic myeloid leukemia, pediatric
- Chronic myelogenous leukemia - historical → Chronic myeloid leukemia - historical
- Chronic myelomonocytic leukaemia → Chronic myelomonocytic leukemia
- Ciltacabtagene autoleucel (JNJ-68284528) → Ciltacabtagene autoleucel (Carvykti)
- Cisplatin → Cisplatin (Platinol)
- Cml → Chronic myeloid leukemia
- Coagulopathies → Acquired coagulopathy
- Colon cancer, BRAF-mutated → Colorectal cancer, BRAF-mutated
- Colon cancer, HER2-positive → Colorectal cancer, HER2-positive
- Colon cancer, KRAS wild-type → Colon cancer, RAS wild-type
- Colon cancer, MSI-H or dMMR → Colorectal cancer, MSI-H or dMMR
- Copanlisib (BAY 80-6946) → Copanlisib (Aliqopa)
- Copyright → HemOnc.org - A Hematology Oncology Wiki:Copyrights
- Crizanlizumab (SEG101) → Crizanlizumab (Adakveo)
- Cytarabine (Cytosar) → Cytarabine (Ara-C)
- Cytarabine and daunorubicin (Vyxeos) → Cytarabine and daunorubicin liposomal (Vyxeos)
- Cytomegalovirus (CMV) Human Immunoglobulin (Cytogam) → Cytomegalovirus Immune Globulin (Cytogam)
- Cytomegalovirus Human Immunoglobulin (CMV Immunoglobulin-VF) → Cytomegalovirus (CMV) Human Immunoglobulin (Cytogam)
- DLBCL → Diffuse large B-cell lymphoma
- DN24-02 → Lapuleucel-T (DN24-02)
- DVT → Venous thromboembolism
- Dacomitinib (PF-00299804) → Dacomitinib (Vizimpro)
- Daratumumab (HuMax-CD38) → Daratumumab (Darzalex)
- Darolutamide (ODM-201) → Darolutamide (Nubeqa)
- Desmoid tumors → Desmoid tumor
- Dexamethasone → Dexamethasone (Decadron)
- Dexrazoxane (Totect) → Dexrazoxane (Zinecard)
- Differentiated thyroid cancer → Thyroid cancer, differentiated
- Doxorubicin liposomal (Doxil) → Pegylated liposomal doxorubicin (Doxil)
- Durvalumab (MEDI4736) → Durvalumab (Imfinzi)
- Duvelisib (IPI-145) → Duvelisib (Copiktra)
- ECOG performance status → Performance status
- EGFR → Malignant solid neoplasm, EGFR-mutated
- ERBB2 (HER2) → Malignant solid neoplasm, ERBB2-mutated
- ERBB3 (HER3) → Malignant solid neoplasm, ERBB3-mutated
- Eculizumab (Bekemv) → Eculizumab-beke (Bekemv)
- Eculizumab (Epysqli) → Eculizumab-epys (Epysqli)
- Elacestrant (RAD1901) → Elacestrant (Orserdu)